Ribavirin: Past, present and future

World Journal of Hepatology
Véronique Loustaud-RattiPaul Carrier

Abstract

Before the advent of direct acting antiviral agents (DAAs) ribavirin, associated to pegylated-interferon played a crucial role in the treatment of chronic hepatitis C, preventing relapses and breakthroughs. In the present era of new potent DAAs, a place is still devoted to the drug. Ribavirin associated with sofosbuvir alone is efficient in the treatment of most cases of G2 infected patients. All options currently available for the last difficult-to-treat cirrhotic G3 patients contain ribavirin. Reducing treatment duration to 12 wk in G1 or G4 cirrhotic compensated patients is feasible thanks to ribavirin. Retreating patients with acquired anti NS5A resistance-associated variants using ribavirin-based strategies could be useful. The addition of ribavirin with DAAs combinations however, leads to more frequent but mild adverse events especially in cirrhotic patients. Preliminary data with interferon-free second generation DAAs combinations without ribavirin suggest that future of the drug is jeopardized even in difficult-to-treat patients: The optimization of ribavirin dosage according to an early monitoring of blood levels has been suggested to be relevant in double therapy with peginterferon or sofosbuvir but not with very pote...Continue Reading

References

Dec 15, 1995·Annals of Internal Medicine·A M Di BisceglieJ H Hoofnagle
Oct 5, 2001·Expert Opinion on Pharmacotherapy·N J Snell
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Oct 3, 2002·Gastroenterology·John G McHutchisonUNKNOWN International Hepatitis Interventional Therapy Group
Oct 19, 2002·Clinical Pharmacology and Therapeutics·Juif JenGerald Hajian
Feb 28, 2004·Gastroenterology·Jean-Michel PawlotskyDaniel Dhumeaux
Jan 22, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Karin LindahlRobert Schvarcz
Feb 28, 2006·Cellular and Molecular Life Sciences : CMLS·N M Dixit, A S Perelson
May 12, 2007·Journal of Virology·Stéphane ChevaliezJean-Michel Pawlotsky
Oct 12, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordan J FeldMichael W Fried
Apr 26, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Véronique Loustaud-RattiElisabeth Vidal
Mar 5, 2011·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver
Apr 24, 2013·The New England Journal of Medicine·Ira M JacobsonUNKNOWN FUSION Study
Apr 12, 2014·The New England Journal of Medicine·Stefan ZeuzemBarry Bernstein
Apr 12, 2014·The New England Journal of Medicine·Kris V KowdleyUNKNOWN ION-3 Investigators
Apr 15, 2014·The New England Journal of Medicine·Jay H Hoofnagle, Averell H Sherker
May 6, 2014·The New England Journal of Medicine·Peter FerenciUNKNOWN PEARL-IV Study
May 6, 2014·The New England Journal of Medicine·Stefan ZeuzemUNKNOWN VALENCE Investigators
Oct 18, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eric LawitzFernando E Membreno
Jan 24, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David R NelsonUNKNOWN ALLY-3 Study Team
Mar 27, 2015·Therapeutic Drug Monitoring·Karin LindahlRobert Schvarcz
Apr 8, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K Rajender ReddyNezam Afdhal
May 6, 2015·JAMA : the Journal of the American Medical Association·Andrew J MuirPhilip D Yin
May 15, 2015·The Journal of Antimicrobial Chemotherapy·Joseph E RowerJennifer J Kiser

❮ Previous
Next ❯

Citations

Nov 1, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J CaoD Chen
Mar 1, 2018·Oncotarget·Joshua CasaosNicolas Skuli
Sep 17, 2020·Clinical and Translational Science·Pablo ZubiaurFrancisco Abad-Santos
May 12, 2020·Frontiers in Microbiology·Longping V TseRalph S Baric
May 26, 2017·Clinical and Experimental Pharmacology & Physiology·Ehab S El DesokyAntonio D'Avolio
Nov 13, 2020·Journal of Biomolecular Structure & Dynamics·Prateek KumarRajanish Giri
Nov 17, 2020·Frontiers in Microbiology·Sushmita PatraJyoti Ranjan Rout
Feb 12, 2019·Biochemical and Biophysical Research Communications·Jing JinAli Deng
Nov 18, 2020·Respiratory Medicine·Mukta AgrawalAmit Alexander
May 1, 2021·Microorganisms·Frederick HansenKyle Rosenke
May 29, 2021·International Journal of Biological Macromolecules·Yuxi GuoPin Gong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Namiki IzumiNobuharu Tamaki
Current Opinion in Gastroenterology
Mitchell L Shiffman
The New England Journal of Medicine
Anna S LokClaudio Pasquinelli
© 2021 Meta ULC. All rights reserved